Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By stimulating these receptors, https://aadamkctl251659.blogdigy.com/retatrutide-a-promising-new-treatment-for-obesity-55165702